DAPT duration after DES: what is the "mandatory" duration?

J Am Coll Cardiol. 2015 Mar 24;65(11):1103-6. doi: 10.1016/j.jacc.2015.01.024.

Authors

Roxana Mehran¹, Gennaro Giustino², Usman Baber²

Affiliations

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: [email protected].
² The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 25790881
DOI: 10.1016/j.jacc.2015.01.024

No abstract available

Keywords: bleeding; major adverse cardiac event(s); stent thrombosis.

Publication types

Editorial
Comment

MeSH terms

Drug-Eluting Stents*
Graft Occlusion, Vascular / prevention & control*
Humans
Myocardial Infarction / prevention & control*
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / administration & dosage*

Substances

Platelet Aggregation Inhibitors